Clinical Trials in Nashville

Showing 20001-20020 of 20,298 trials

A Prospective Study of Radiation Exposure to Surgeons

NCT00378053

The purpose of this study is to measure the amount of radiation over a specific period of time that Orthopaedic Surgeons are exposed to while using the mini c-arm fluoroscopy machine.

Radiation Exposure

Vanderbilt University4 participantsStarted Sep 2006

Nashville, Tennessee, United States

COMPLETEDPhase 2< 1 mile

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

NCT00264433

N-cadherin, a protein involved in blood vessel cell binding, is increased as cancer progresses, and is on the surface of many tumor cells. ADH-1 blocks N-cadherin. This study will test the safety and effects of ADH-1 in subjects with specific incurable, solid tumors with a protein biomarker called N-cadherin. This study will examine the clinical activity of ADH-1.

Neoplasms

Adherex Technologies, Inc.

Fort Myers, Florida, United States • Chapel Hill, North Carolina, United States • Durham, North Carolina, United States +8 more locations

COMPLETEDPhase 4< 1 mile

A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

NCT00510913

A study to compare the conversion to Prograf® (tacrolimus) to the continuation of cyclosporine in patients at risk for chronic renal allograft failure

Graft RejectionKidney Transplantation

Astellas Pharma Inc450 participantsStarted Feb 1999

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +15 more locations

A Prospective Study of Radiation Exposure to Surgeons

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

Find Trials by Condition in Nashville

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Treatment of Infertility in Women With Polycystic Ovary Syndrome

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis

Study of Antiepileptic Drug Effects on Child Development

Meditation-Based Treatment for Binge Eating Disorder

A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension